Application 213864
- Type
- ANDA
- Sponsor
- MANKIND PHARMA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | FENOFIBRATE | FENOFIBRATE | TABLET;ORAL | 54MG | No | No |
| 002 | FENOFIBRATE | FENOFIBRATE | TABLET;ORAL | 160MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A213864-001 | FENOFIBRATE | FENOFIBRATE | 54MG | TABLET / ORAL | AB | 2020-06-12 | |
| A213864-002 | FENOFIBRATE | FENOFIBRATE | 160MG | TABLET / ORAL | AB | 2020-06-12 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A213864-001 | AB |
| A213864-002 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A213864-001 | FENOFIBRATE | 54MG | TABLET / ORAL | AB | 2020-06-12 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A213864-002 | FENOFIBRATE | 160MG | TABLET / ORAL | AB | 2020-06-12 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A213864-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A213864-002 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| FENOFIBRATE | FENOFIBRATE | REMEDYREPACK INC. | 3b6c5ebd-a8bc-4502-8b66-f4e58914815b | 2026-07-30 | Warnings, Adverse reactions | 213864 ANDA213864 70518-2907 |
| FENOFIBRATE | FENOFIBRATE | St. Mary's Medical Park Pharmacy | b92fb19a-d0df-426e-e053-2995a90ab379 | 2026-06-02 | Warnings, Adverse reactions | 213864 ANDA213864 60760-318 |
| FENOFIBRATE | FENOFIBRATE | A-S Medication Solutions | df9f67d6-3cd9-4f44-8020-2d6ef53c30b5 | 2026-05-08 | Warnings, Adverse reactions | 213864 ANDA213864 |
| FENOFIBRATE | FENOFIBRATE | Preferred Pharmaceuticals Inc. | e573b3f1-5a4c-4a19-9f0f-ee797b379a08 | 2026-04-15 | Warnings, Adverse reactions | 213864 ANDA213864 68788-7816 |
| FENOFIBRATE | FENOFIBRATE | A-S Medication Solutions | f443dd79-46da-4b02-8188-7417d39cf975 | 2026-03-10 | Warnings, Adverse reactions | 213864 ANDA213864 |
| FENOFIBRATE | FENOFIBRATE | REMEDYREPACK INC. | b79efcf4-6016-4a1f-b83f-be00baa25c21 | 2026-02-13 | Warnings, Adverse reactions | 213864 ANDA213864 70518-2947 |
| FENOFIBRATE | FENOFIBRATE | Northwind Health Company, LLC | f7590970-c54d-24e9-e053-6294a90ac400 | 2026-01-01 | Warnings, Adverse reactions | 213864 ANDA213864 |
| FENOFIBRATE | FENOFIBRATE | NorthStar RxLLC | 3b448774-aebf-45fe-92f1-b8eca53cf09b | 2025-09-13 | Warnings, Adverse reactions | 213864 ANDA213864 |
| FENOFIBRATE | FENOFIBRATE | Major Pharmaceuticals | 3f4e5db8-5bfb-4b24-8465-9757cbaad2be | 2025-06-02 | Warnings, Adverse reactions | 213864 ANDA213864 |
| FENOFIBRATE | FENOFIBRATE | Lifestar Pharma LLC | 1da57e8c-3977-43e1-aa7e-229760203f7d | 2025-05-28 | Warnings, Adverse reactions | 213864 ANDA213864 70756-215 70756-214 |
| FENOFIBRATE | FENOFIBRATE | Bryant Ranch Prepack | d34f9fa3-39ae-4b8e-8f29-0d5c655c50b5 | 2023-03-31 | Warnings, Adverse reactions | 213864 ANDA213864 71335-1756 |
| FENOFIBRATE | FENOFIBRATE | Proficient Rx LP | 26f8f793-fb7a-4327-9441-d8737fe1ff11 | 2022-06-01 | Warnings, Adverse reactions | 213864 ANDA213864 71205-666 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 60760-318 | FENOFIBRATE | FENOFIBRATE | St. Mary's Medical Park Pharmacy | ANDA | Current |
| 60760-318 | FENOFIBRATE | FENOFIBRATE | St. Mary's Medical Park Pharmacy | ANDA | Current |
| 68071-2540 | FENOFIBRATE | FENOFIBRATE | NuCare Pharmaceuticals,Inc. | ANDA | Current |
| 68071-2540 | FENOFIBRATE | FENOFIBRATE | NuCare Pharmaceuticals,Inc. | ANDA | Current |
| 68788-7816 | FENOFIBRATE | FENOFIBRATE | Preferred Pharmaceuticals Inc. | ANDA | Current |
| 68788-7816 | FENOFIBRATE | FENOFIBRATE | Preferred Pharmaceuticals Inc. | ANDA | Current |
| 68788-7816 | FENOFIBRATE | FENOFIBRATE | Preferred Pharmaceuticals Inc. | ANDA | Current |
| 70518-2907 | FENOFIBRATE | FENOFIBRATE | REMEDYREPACK INC. | ANDA | Current |
| 70518-2907 | FENOFIBRATE | FENOFIBRATE | REMEDYREPACK INC. | ANDA | Current |
| 70518-2947 | FENOFIBRATE | FENOFIBRATE | REMEDYREPACK INC. | ANDA | Current |
| 70518-2947 | FENOFIBRATE | FENOFIBRATE | REMEDYREPACK INC. | ANDA | Current |
| 70756-214 | FENOFIBRATE | FENOFIBRATE | Lifestar Pharma LLC | ANDA | Current |
| 70756-214 | FENOFIBRATE | FENOFIBRATE | Lifestar Pharma LLC | ANDA | Current |
| 70756-214 | FENOFIBRATE | FENOFIBRATE | Lifestar Pharma LLC | ANDA | Current |
| 70756-215 | FENOFIBRATE | FENOFIBRATE | Lifestar Pharma LLC | ANDA | Current |
| 70756-215 | FENOFIBRATE | FENOFIBRATE | Lifestar Pharma LLC | ANDA | Current |
| 70756-215 | FENOFIBRATE | FENOFIBRATE | Lifestar Pharma LLC | ANDA | Current |
| 71205-666 | FENOFIBRATE | FENOFIBRATE | Proficient Rx LP | ANDA | Current |
| 71335-1756 | FENOFIBRATE | FENOFIBRATE | Bryant Ranch Prepack | ANDA | Current |